EICHOR
● Recruiting
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
Condition: Osteoarthritis · Sponsor: VivaTech International, Inc.
About this study
This is a prospective open-label clinical study of 50 patients to determine safety and treatment potential of autologous cell therapy for pain and inflammation associated with Osteoarthritis of the knee. Follow-up will consist of a larger sample including 4,000 patients.
This description comes directly from the study's public registry record.
Talk to the study team
Scott M Herkes, MBA · 855-984-8287 · scott.herkes@gmail.com
Michael P Hutchinson, DVM · 412-503-3788 · drmike@vivatechusa.com
Always discuss trial participation with your own doctor first.
Locations (1)
| VivaTech International, Inc. | Grove City, Pennsylvania, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.